-
17/06/2025
When the world fell silent: The role of in silico medicine during the COVID-19 crisis. Part 2/3
In this second episode of our series on in silico medicine during the COVID-19 response, we explore how computer models helped optimise vaccine doses, test therapies, as well as simulate immune responses, virtually—saving time, reducing risk, and guiding smarter, faster decisions in a race against the clock.
-Read more-
-
12/06/2025
Exploring Trust and Public Engagement in in silico medicine at STS Italia 2025
Delegates from the VPH at the Science and Technology Studies Italia (STS Italia) conference in Milan
-Read more-
-
09/06/2025
PhD and postdoc opportunities - June 2025
-
04/06/2025
VPH commends EMA's Mechanistic Modelling Guideline Initiative urging broader scope
On 30 May 2025, VPH presented its formal comments and suggestions on the European Medicines Agency's (EMA) proposed guideline for assessing and reporting mechanistic models in the context of model informed drug development (EMA 2025).
-Read more-
-
04/06/2025
New funding opportunities for the in silico medicine community
The European Commission has announced the Health and Research Infrastructures 2025 Work Programmes and these programmes contain several opportunities in the in silico medicine domain.
-Read more-
-
03/06/2025
News from the 8th VPH Summer School this week in Barcelona
The Summer School provides junior engineers, early researchers and medical doctors with an integrative view of state-of-the-art research for in silico medicine, following a complete pipeline from basic science and clinical needs, to model application.
-Read more-
-
29/05/2025
VPH engages with regulatory and policy stakeholders at the annual RAPS Euro Convergence conference
Held from 13 to 16 May 2025 in Brussels, the RAPS Euro Convergence conference is the Europe's premier regulatory affairs event for healthcare products.
-Read more-
-
28/05/2025
Parliamentary question on use of non-human primates in experiments and phasing out animal testing
On 30 April 2025, MEP Niels Fuglsang submitted a parliamentary question (E-001722/2025) to the European Commission concerning the use of non-human primates in animal testing.
-Read more-